Stocktoria
QTREX Quantum Ltd. QTEX
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2021-07-13
QTREX Quantum Ltd. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $289,000 | $0 | $0 | — |
| Gross profit | $2,000 | $0 | $0 | — |
| R&D expense | $7.5M | $6.3M | $7.3M | $8.2M |
| Operating income | -$13.6M | -$11.3M | -$12.1M | -$14.9M |
| Interest expense | — | — | $1.2M | — |
| Income tax | $0 | $0 | $0 | — |
| Net income | -$13.2M | -$11.1M | -$11.3M | -$15.0M |
| EPS (diluted) | $-0.45 | $-0.60 | $-0.93 | $-1.39 |
| Operating cash flow | -$9.9M | -$9.4M | -$9.7M | -$9.2M |
| Free cash flow | -$10.0M | -$9.5M | -$9.9M | -$9.5M |
| Cash & equivalents | $3.2M | $5.1M | $5.0M | $6.8M |
| Inventory | $735,000 | $444,000 | — | — |
| Total assets | $5.3M | $8.1M | $9.3M | $16.2M |
| Shareholders' equity | $2.3M | $4.3M | $5.7M | $13.6M |
Source: SEC EDGAR filings · CIK 0001837493 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.